Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state.

Merindol N, El-Far M, Sylla M, Masroori N, Dufour C, Li JX, Cherry P, Plourde MB, Tremblay C, Berthoux L.

PLoS Pathog. 2018 Nov 12;14(11):e1007398. doi: 10.1371/journal.ppat.1007398. eCollection 2018 Nov.

2.

Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1.

Dufour C, Claudel A, Joubarne N, Merindol N, Maisonnet T, Masroori N, Plourde MB, Berthoux L.

PLoS One. 2018 Jan 26;13(1):e0191709. doi: 10.1371/journal.pone.0191709. eCollection 2018.

3.

Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines.

Masroori N, Cherry P, Merindol N, Li JX, Dufour C, Poulain L, Plourde MB, Berthoux L.

mSphere. 2017 Jun 21;2(3). pii: e00233-17. doi: 10.1128/mSphereDirect.00233-17. eCollection 2017 May-Jun.

4.

A putative SUMO interacting motif in the B30.2/SPRY domain of rhesus macaque TRIM5α important for NF-κB/AP-1 signaling and HIV-1 restriction.

Nepveu-Traversy MÉ, Demogines A, Fricke T, Plourde MB, Riopel K, Veillette M, Diaz-Griffero F, Sawyer SL, Berthoux L.

Heliyon. 2016 Jan 21;2(1):e00056. doi: 10.1016/j.heliyon.2015.e00056. eCollection 2016 Jan.

5.
6.

Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration.

Pizzato M, McCauley SM, Neagu MR, Pertel T, Firrito C, Ziglio S, Dauphin A, Zufferey M, Berthoux L, Luban J.

PLoS Pathog. 2015 Jul 16;11(7):e1005050. doi: 10.1371/journal.ppat.1005050. eCollection 2015 Jul.

7.

Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 Transgene.

Jung U, Urak K, Veillette M, Nepveu-Traversy MÉ, Pham QT, Hamel S, Rossi JJ, Berthoux L.

Hum Gene Ther. 2015 Oct;26(10):664-79. doi: 10.1089/hum.2015.059. Epub 2015 Aug 6.

8.

Restriction Factors in HIV-1 Disease Progression.

Merindol N, Berthoux L.

Curr HIV Res. 2015;13(6):448-61. Review.

PMID:
26051387
9.

Inhibition of microtubules and dynein rescues human immunodeficiency virus type 1 from owl monkey TRIMCyp-mediated restriction in a cellular context-specific fashion.

Pawlica P, Dufour C, Berthoux L.

J Gen Virol. 2015 Apr;96(Pt 4):874-86. doi: 10.1099/jgv.0.000018. Epub 2014 Dec 12.

PMID:
25502651
10.

Cytoplasmic dynein promotes HIV-1 uncoating.

Pawlica P, Berthoux L.

Viruses. 2014 Nov 4;6(11):4195-211. doi: 10.3390/v6114195.

11.

Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.

Pawlica P, Le Sage V, Poccardi N, Tremblay MJ, Mouland AJ, Berthoux L.

J Virol. 2014 May;88(10):5661-76. doi: 10.1128/JVI.03717-13. Epub 2014 Mar 5.

12.

The conserved sumoylation consensus site in TRIM5α modulates its immune activation functions.

Nepveu-Traversy MÉ, Berthoux L.

Virus Res. 2014 May 12;184:30-8. doi: 10.1016/j.virusres.2014.02.013. Epub 2014 Feb 25.

PMID:
24583231
13.

The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.

Veillette M, Bichel K, Pawlica P, Freund SM, Plourde MB, Pham QT, Reyes-Moreno C, James LC, Berthoux L.

Retrovirology. 2013 Feb 28;10:25. doi: 10.1186/1742-4690-10-25.

14.

The Bcl-2/Bcl-xL inhibitor BH3I-2' affects the dynamics and subcellular localization of sumoylated proteins.

Plourde MB, Morchid A, Iranezereza L, Berthoux L.

Int J Biochem Cell Biol. 2013 Apr;45(4):826-35. doi: 10.1016/j.biocel.2013.01.013. Epub 2013 Jan 31.

PMID:
23375957
15.

A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen.

Pham QT, Veillette M, Brandariz-Nuñez A, Pawlica P, Thibert-Lefebvre C, Chandonnet N, Diaz-Griffero F, Berthoux L.

Virus Res. 2013 May;173(2):306-314. doi: 10.1016/j.virusres.2013.01.013. Epub 2013 Jan 25.

16.

Murine double minute 2 as a modulator of retroviral restrictions mediated by TRIM5alpha.

Malbec M, Pham QT, Plourde MB, Létourneau-Hogan A, Nepveu-Traversy ME, Berthoux L.

Virology. 2010 Sep 30;405(2):414-23. doi: 10.1016/j.virol.2010.06.021. Epub 2010 Jul 8.

17.

Generation of human TRIM5alpha mutants with high HIV-1 restriction activity.

Pham QT, Bouchard A, Grütter MG, Berthoux L.

Gene Ther. 2010 Jul;17(7):859-71. doi: 10.1038/gt.2010.40. Epub 2010 Apr 1.

PMID:
20357830
18.

Cell context-dependent involvement of ATR in early stages of retroviral replication.

Yang YX, Guen V, Richard J, Cohen EA, Berthoux L.

Virology. 2010 Jan 20;396(2):272-9. doi: 10.1016/j.virol.2009.10.032. Epub 2009 Nov 13.

19.
20.

Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells.

Bérubé J, Bouchard A, Berthoux L.

Retrovirology. 2007 Sep 24;4:68.

21.

The role of lysine 186 in HIV-1 integrase multimerization.

Berthoux L, Sebastian S, Muesing MA, Luban J.

Virology. 2007 Jul 20;364(1):227-36. Epub 2007 Mar 29.

22.

G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer.

Zhang S, Joseph G, Pollok K, Berthoux L, Sastry L, Luban J, Cornetta K.

Mol Ther. 2006 Oct;14(4):546-54. Epub 2006 Aug 9.

23.
24.

Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.

Berthoux L, Sebastian S, Sokolskaja E, Luban J.

Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14849-53. Epub 2005 Oct 3.

25.

Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.

Berthoux L, Sebastian S, Sayah DM, Luban J.

J Virol. 2005 Jun;79(12):7883-8.

26.

Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1.

Gurer C, Berthoux L, Luban J.

J Virol. 2005 Jan;79(2):910-7.

27.
28.

Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1.

Sayah DM, Sokolskaja E, Berthoux L, Luban J.

Nature. 2004 Jul 29;430(6999):569-73. Epub 2004 Jul 7.

PMID:
15243629
29.

Chondrocyte transplantation into articular cartilage defects with use of calcium alginate: the fate of the cells.

Mierisch CM, Wilson HA, Turner MA, Milbrandt TA, Berthoux L, Hammarskjöld ML, Rekosh D, Balian G, Diduch DR.

J Bone Joint Surg Am. 2003 Sep;85(9):1757-67.

PMID:
12954835
30.

Tracing transduced cells in osteochondral defects.

Milbrandt T, Berthoux L, Christenson V, Baumbusch C, Rekosh D, Balian G, Diduch D.

J Pediatr Orthop. 2003 Jul-Aug;23(4):430-6.

PMID:
12826937
31.

As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.

Berthoux L, Towers GJ, Gurer C, Salomoni P, Pandolfi PP, Luban J.

J Virol. 2003 Mar;77(5):3167-80.

32.

Vascular injury induces posttranscriptional regulation of the Id3 gene: cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis.

Matsumura ME, Li F, Berthoux L, Wei B, Lobe DR, Jeon C, Hammarskjöld ML, McNamara CA.

Arterioscler Thromb Vasc Biol. 2001 May;21(5):752-8. Erratum in: Arterioscler Thromb Vasc Biol 2001 Aug;21(8):1384.

PMID:
11348870
33.

Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs.

Darlix JL, Cristofari G, Rau M, Péchoux C, Berthoux L, Roques B.

Adv Pharmacol. 2000;48:345-72. Review. No abstract available.

PMID:
10987096
34.
35.

[Palliative treatment of adenocarcinoma of the cardia: is there a role for surgery?].

Schmitt G, Sauvanet A, Berthoux L, Valverde A, Dugué L, Fékété F, Belghiti J.

Gastroenterol Clin Biol. 1998 Aug-Sep;22(8-9):669-74. French.

36.

[Results of the surgical treatment of cancer of the cardia].

Fékété F, Sauvanet A, Berthoux L, Flejou JF, Gayet B.

J Chir (Paris). 1997 Nov;134(5-6):202-8. French.

PMID:
9772973
37.

Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication.

Tanchou V, Decimo D, Péchoux C, Lener D, Rogemond V, Berthoux L, Ottmann M, Darlix JL.

J Virol. 1998 May;72(5):4442-7.

38.
39.

A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis.

Paillart JC, Berthoux L, Ottmann M, Darlix JL, Marquet R, Ehresmann B, Ehresmann C.

J Virol. 1996 Dec;70(12):8348-54.

40.

Laparoscopic mobilization of the stomach for oesophageal replacement.

Jagot P, Sauvanet A, Berthoux L, Belghiti J.

Br J Surg. 1996 Apr;83(4):540-2.

PMID:
8665254
41.

[Adenocarcinoma of the cardia: does the extent of gastric resection and lymph node excision influence survival?].

Sauvanet A, Berthoux L, Gayet B, Fléjou JF, Belghiti J, Fékété F.

Gastroenterol Clin Biol. 1995 Mar;19(3):244-51. French.

PMID:
7540158
42.

[Imaging of cancer of the esophagus: ultrasound-endoscopy or computed tomography?].

Fékété F, Sauvanet A, Zins M, Berthoux L, Amouyal G.

Ann Chir. 1995;49(7):573-8; discussion 578-9. French.

PMID:
8554267
43.

Associated primary esophageal and lung carcinoma: a study of 39 patients.

Fékété F, Sauvanet A, Kaisserian G, Jauffret B, Zouari K, Berthoux L, Flejou JF.

Ann Thorac Surg. 1994 Sep;58(3):837-42.

PMID:
7524458
44.

[Perineal hernia after abdominoperineal amputation. Role of epiploplasty and/or irradiation].

Berthoux L, Labib A, Clough KB, Girodet J, Salmon RJ.

J Chir (Paris). 1992 Dec;129(12):550-2. French.

PMID:
1299670
45.

[Long-term results of mastectomy in surgically treatble cancers at the Institut Curie from 1960 to 1973].

Berthoux L, Asselain B, Vilcoq JR, Salmon RJ.

J Chir (Paris). 1990 Jan;127(1):1-5. French.

PMID:
2312625
46.
47.
48.

[Resections of hepatocellular carcinomas in cirrhosis: results of a prospective study of 28 resections].

Smadja C, Berthoux L, Kahwaji F, Kemeny F, Grange D, Franco D.

Gastroenterol Clin Biol. 1988 Feb;12(2):93-8. French.

PMID:
2835279
49.

[Value of total pedicle clamping in hepatic excision for hepatocellular carcinoma in cirrhotic patients].

Smadja C, Kahwaji F, Berthoux L, Grange D, Franco D.

Ann Chir. 1987;41(9):639-42. French. No abstract available.

PMID:
2830834

Supplemental Content

Loading ...
Support Center